The MHRA’s recent fees consultation contains a proposal to charge annual fees, per GMDN code. If implemented, this would significantly increase costs for the IVD industry – to the point were some products are likely to be commercially unviable. While BIVDA understand the MHRA’s intention for industry to fund its activities, this proposal is likely to mean large price rises…
Ben KempSeptember 17, 2024